Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Agreements

"WHEREAS, it is in the mutual interest of the Parties to facilitate the selection of a new MMP Program Vendor by PTSC to replace TPL; and,WHEREAS, the following collateral undertakings between the parties may expedite that process."

OK, legal beagles and financial fiends, is this sort of re-arranging of deckchairs symptomatic of the preparation for TPL to file for bankruptcy?

Share
New Message
Please login to post a reply